Clean Science & Technology Ltd. · NSE:CLEAN
Clean Science & Technology — Q4 FY2025 Earnings Presentation
23 slides from Clean Science & Technology's earnings presentation, May 22, 2025
Slide 1: Intimation of Investor Presentation to stock exchanges
�'� � Res�onsible Care" 0URC0MM/TM(HTT05USlAJHABILIN 22.05.2025 To BSE Limited National Stock Exchange of India Limited Phiroze JeeJeebhoy Towers, Exchange Plaza, Plot no. C/1, Dalal Street, G Block, Bandra-Kurla Complex Fort, Mumbai - 400 001 Bandra (E), Mumbai - 400 051 Scrip Code: 543318 Trading
Slide 2: Clean Science and Technology Ltd. Investor Presentation Q4 FY2025
Clean Science and Technology Ltd. Investor Presentation Q4 FY 2025 I MAY 2025
Slide 3: Safe Harbour
SAFE HARBOUR This investor presentation has been prepared by Clean Science and Technology Limited (“CSTL”) and does not constitute a prospectus or placement memorandum or an offer to acquire any securities. This presentation or any other documentation or information (or any part thereof) delivered o
Slide 4: Q4 FY2025 & FY2025 Update
Q4 FY 2025 & FY2025 Update
Slide 5: Q4 FY2025 Update
Q4 FY2025 UPDATE Volume led revenue growth; EBITDA margins are steady Revenue in INR Crore 188 181 195 225 217 228 232 245 Q1 FY24 Q2 FY24 Q3 FY24 Q4 FY24 Q1 FY25 Q2 FY25 Q3 FY25 Q4 FY25 41.3% 42.4% 44.9% 44.4% 45.5% 42.1% 44.8% 43.8% 39.2% 36.6% 35.7% 37.3% 34.7% 33.6% 34.4% 34.1% 9.5% 9.0% 7.9% 8.
Slide 6: Q4 FY2025 and FY2025 P&L Overview - Standalone
Q4 FY2025 and FY2025 P&L OVERVIEW - STANDALONE Recorded highest sales volumes across key products during the year P&L (INR Crore) Q4 FY2025 Q3 FY2025 Q-o-Q (%) Q4 FY2024 Y-o-Y (%) FY 2025 FY 2024 Y-o-Y (%) Sale of products 238 228 4% 222 7% 906 778 17% Other operating income 7 3 3 16 12 Total Revenu
Slide 7: Q4 FY2025 and FY2025 P&L Overview - Consolidated
Q4 FY2025 and FY2025 P&L OVERVIEW - CONSOLIDATED Contribution from newly launched products improving while EBITDA margins continue to be strong P&L (INR Crore) Q4 FY2025 Q3 FY2025 Q-o-Q (%) Q4 FY2024 Y-o-Y (%) FY 2025 FY 2024 Y-o-Y (%) Sale of products 256 237 8% 224 14% 950 780 22% Other operating
Slide 8: FY2025 Balance Sheet Overview
FY2025 BALANCE SHEET OVERVIEW Healthy cash balance to fund ongoing capex Standalone Balance Sheet As at As at Consolidated Balance Sheet As at As at (INR Crore) 31-March-2025 31-March-2024 (INR Crore) 31-March-2025 31-March-2024 Assets Assets Non-current assets Non-current assets Fixed Assets 360 39
Slide 9: FY2025 - Revenue Profile
FY2025 – REVENUE PROFILE Performance and Pharma segment led the revenue growth REVENUE MIX BY SEGMENT REVENUE MIX BY GEOGRAPHY 12% 13% 10% 10% 35% 36% 19% 22% 22% 19% FY2025 FY2024 FY2025 FY2024 69% 67% 15% 14% 17% 17% Performance Pharma & Agro FMCG China India Europe Americas Row chemicals Intermed
Slide 10: Corporate presentation
Corporate presentation
Slide 11: Clean Science and Technology at a Glance
CLEAN SCIENCE AND TECHNOLOGY AT A GLANCE A brief Introduction about the Company ➢ One of the fastest growing and among the most profitable fine and specialty chemical companies globally. Among the largest manufacturers of certain specialty chemicals developed in-house. ➢ Among the few global organiz
Slide 12: Company Evolution
COMPANY EVOLUTION Continuous R&D and Innovation has led to new product launches on a consistent basis YEAR 2009 2011 2014 2018 2020 2021 2022 2023 2024 REVENUES (INR Crore) 1 19 120 241 419 512 685 936 789 ➢ Commercialized largest plant for ➢ Commercialized plant HALS from India to manufacture P-BQ
Slide 13: Diversified Product Profile Serving Critical End-User Industries
DIVERSIFIED PRODUCT PROFILE SERVING CRITICAL END-USER INDUSTRIES Largest capacity in the world for our flagship products PERFORMANCE PHARMA AND AGRO FMCG CHEMICALS INTERMEDIATES CHEMICALS MEHQ (Monomethyl Ether of Hydroquinone) Guaiacol 4-MAP (4-Methoxy Acetophenone) ➢ Used as polymerization inhibit
Slide 14: Key Differentiators That Add Value
KEY DIFFERENTIATORS THAT ADD VALUE Unique benefits that set our business apart from competition INNOVATION GLOBAL LEADERS PREFERRED PARTNER STATE-OF-THE-ART Strategic process innovation Among the largest OF CHOICE Multiple, automated and new product producers globally of Strong and long term manufac
Slide 15: Steadfast Focus on Research & Development
STEADFAST FOCUS ON RESEARCH & DEVELOPMENT Pioneered commercialization of catalytic reactions Research and Development team’s focus areas Enhance our existing catalyst Develop products with high demand Expand product portfolio in the 1 systems to further optimize yield 2 performance chemical segment
Slide 16: Cohesive and Technocrat Promoters
COHESIVE AND TECHNOCRAT PROMOTERS Strong visibility on longevity of Promoters’ engagement in the business Over 30 years of work experience in Over 20 years of experience in the the chemical industry. chemical industry. Industry experience of over 5 decades Bachelor of Chemical Technology – Institute
Slide 17: Robust Corporate Governance
ROBUST CORPORATE GOVERNANCE Distinguished Board of Directors and reputed financial market participants underscore sound governance PROFILE OF NON-EXECUTIVE, INDEPENDENT DIRECTORS ON THE BOARD PRADEEP RATHI PROF. G. D. YADAV Sanjay Kothari Chairman and Non-Executive Director Non-Executive, Independen
Slide 18: Continued Commitment Towards Sustainability and ESG
CONTINUED COMMITMENT TOWARDS SUSTAINABILITY AND ESG Sustainability and ESG initiatives are embedded in our long term growth strategy ENVIRONMENT EMPATHY (E) SOCIAL RESPONSIBILITY (S) CORPORATE GOVERNANCE (G) ➢ Utilize resources efficiently, reduce waste ➢ Total contribution towards CSR activities ➢
Slide 19: Advanced Manufacturing Facilities Designed by In-House Engineering Team
ADVANCED MANUFACTURING FACILITIES DESIGNED BY IN-HOUSE ENGINEERING TEAM 3 independent functional units under CSTL at Kurkumbh Industrial Area, Maharashtra with dedicated lines for each product UNIT 1 NO plant closure notice received from pollution 7 plants control board Total area – 30,000 sq.m All
Slide 20: Commercialized Largest Facility for HALS from India
COMMERCIALIZED LARGEST FACILITY FOR HALS FROM INDIA Largest facility of Clean Science Group housed in its wholly owned subsidiary, Clean Fino Chem Ltd. at Kurkumbh Industrial Area, Maharashtra UNIT 4 Commercialized in March 2024 Total area – 1,32,700 sq.mtrs. (34 acres) Cost advantage - Tax incentiv
Slide 21: Strong Financial Performance
STRONG FINANCIAL PERFORMANCE Resilient performance demonstrated over business cycles maintaining a debt free balance sheet REVENUE EBITDA & EBITDA% PAT & PAT% CAGR of 17% EBITDA CAGR of 16% PAT CAGR of 15% 419 512 685 936 789 185 259 300 403 337 140 198 229 304 248 51% 39% 33% 33% 44% 32% 44% 43% 31
Slide 22: Our Key Growth Drivers
KEY GROWTH LEVERS Strategic initiatives and investments aimed at long term sustainable growth FOCUS ON ESG AND SIGNIFICANT SUSTAINABILITY GREENFIELD CAPEX Capitalise on our core philosophy Planned capex on track for of clean and green chemistry to commercialising new series of address opportunities
Slide 23: Thank You
THANK YOU For further information, please contact: PRATIK BORA Email: pratik@cleanscience.co.in Clean Science and Technology Limited Website: https://www.cleanscience.co.in/
Clean Science and Technology — Q4 FY2025 Earnings Presentation on 6ix